Batu Biologics CEO to Moderate Congressional Immunotherapy Symposium

Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium

Congressional Candidate to Hear Concerns of Industry Leaders in Health Care Innovations

Batu Biologics, a clinical stage immunotherapy company, announced today its Chief Executive Officer, Samuel Wagner, was chosen to moderate an internationally renowned panel of biotechnology companies focusing on immunotherapy.

Read the full article at businesswire.com

0